Xiao-Yan Zeng

Prof. Dr. Xiao-Yan Zeng

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2021 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
HLHao-Nan Li
Hao-Nan Li
QYQing-Qing Yang
Qing-Qing Yang
WWWen-Tao Wang
Wen-Tao Wang
XTXue Tian
Xue Tian
FFFan Feng
Fan Feng
XZXiao-Yan Zeng
Xiao-Yan Zeng
Background: Our recent studies have identified that the red nucleus (RN) dual-directionally modulates the development and maintenance of mononeuropathic pain through secreting proinflammatory and anti-inflammatory cytokines. Here, we further explored the action of red nucleus IL-33 in the early development of mononeuropathic pain. Methods: In this study, male rats with spared nerve injury (SNI) were used as mononeuropathic pain model. Immunohistochemistry, Western blotting, and behavioral testing were used to assess the expressions, cellular distributions, and actions of red nucleus IL-33 and its related downstream signaling molecules. Results: IL-33 and its receptor ST2 were constitutively expressed in the RN in naive rats. After SNI, both IL-33 and ST2 were upregulated significantly at 3 days and peaked at 1 week post-injury, especially in RN neurons, oligodendrocytes, and microglia. Blockade of red nucleus IL-33 with anti-IL-33 neutralizing antibody attenuated SNI-induced mononeuropathic pain, while intrarubral administration of exogenous IL-33 evoked mechanical hypersensitivity in naive rats. Red nucleus IL-33 generated an algesic effect in the early development of SNI-induced mononeuropathic pain through activating NF-κB, ERK, p38 MAPK, and JAK2/STAT3, suppression of NF-κB, ERK, p38 MAPK, and JAK2/STAT3 with corresponding inhibitors markedly attenuated SNI-induced mononeuropathic pain or IL-33-evoked mechanical hypersensitivity in naive rats. Red nucleus IL-33 contributed to SNI-induced mononeuropathic pain by stimulating TNF-α expression, which could be abolished by administration of inhibitors against ERK, p38 MAPK, and JAK2/STAT3, but not NF-κB. Conclusions: These results suggest that red nucleus IL-33 facilitates the early development of mononeuropathic pain through activating NF-κB, ERK, p38 MAPK, and JAK2/STAT3. IL-33 mediates algesic effect partly by inducing TNF-α through activating ERK, p38 MAPK and JAK2/STAT3.

7 May 2020 in Neuropathology
Verified
Journal Article
Closed access
PDF file
QYQing‐Qing Yang
Qing‐Qing Yang
HLHao‐Nan Li
Hao‐Nan Li
SZShu‐Ting Zhang
Shu‐Ting Zhang
YYYan‐Li Yu
Yan‐Li Yu
WWWei Wei
Wei Wei
XZXiao-Yan Zeng
Xiao-Yan Zeng

1 February 2018 in Experimental Neurology
Verified
Journal Article
Closed access
CDCui-Ping Ding
Cui-Ping Ding
YGYi-Jie Guo
Yi-Jie Guo
HLHao-Nan Li
Hao-Nan Li
JWJun-Yang Wang
Jun-Yang Wang
XZXiao-Yan Zeng
Xiao-Yan Zeng

13 September 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
CSChenghua Song
Chenghua Song
RWRuichao Wen
Ruichao Wen
JZJiaxuan Zhou
Jiaxuan Zhou
XZXiao-Yan Zeng
Xiao-Yan Zeng
ZKZi Kou
Zi Kou
RWRongqian Wu
Rongqian Wu
The increasing resistance of human pathogens promotes the development of novel antimicrobial agents. Due to the physical bactericidal mechanism of membrane disruption, antimicrobial peptides are considered as potential therapeutic candidates without inducing microbial resistance. Scorpion venom-derived peptide, Androctonus amoreuxi Antimicrobial Peptide 1 (AamAP1), has been proved to have broad-spectrum antimicrobial properties. However, AamAP1 can induce hemolysis and shows strong toxicity against mammalian cells. Herein, the antimicrobial activity and mechanism of a novel synthetic antimicrobial peptide, GK-19, derived from AamAP1 and its derivatives, was evaluated. Five bacteria and three fungi were used to evaluate the antimicrobial effects of GK-19 in vitro. Scalded mice models combined with skin and soft tissue infections (SSTIs) were used to evaluate its applicability. The results indicated that GK-19 could not only inhibit Gram-positive and Gram-negative bacterial growth, but also kill fungi by disrupting the microbial cell membrane. Meanwhile, GK-19 showed negligible toxicity to mammalian cells, low hemolytic activity and high stability in plasma. Furthermore, in scalded mice models combined with SSTIs induced by either Methicillin-Resistant Staphylococcus aureus (MRSA) or Candida albicans, GK-19 showed significant antimicrobial and healing effects. Overall, it was demonstrated that GK-19 might be a promising drug candidate in the battle against drug-resistant bacterial and fungal infections.

8 April 2022 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
QYQing-Qing Yang
Qing-Qing Yang
HLHao-Nan Li
Hao-Nan Li
YXYu-Tong Xia
Yu-Tong Xia
XTXue Tian
Xue Tian
FFFan Feng
Fan Feng
XZXiao-Yan Zeng
Xiao-Yan Zeng
Our previous studies have clarified that red nucleus (RN) interleukin (IL)-6 is involved in the maintenance of neuropathic pain and produces a facilitatory effect by activating JAK2/STAT3 and ERK pathways. In this study, we further explored the immune molecular mechanisms of rubral IL-6-mediated descending facilitation at the spinal cord level. IL-6-evoked tactile allodynia was established by injecting recombinant IL-6 into the unilateral RN of naive male rats. Following intrarubral administration of IL-6, obvious tactile allodynia was evoked in the contralateral hindpaw of rats. Meanwhile, the expressions of pro-inflammatory cytokines tumor necrosis factor-α (TNF-α), IL-1β, and IL-6 were elevated in the contralateral spinal dorsal horn (L4–L6), blocking spinal TNF-α, IL-1β, or IL-6 with neutralizing antibodies relieved IL-6-evoked tactile allodynia. Conversely, the levels of anti-inflammatory cytokines transforming growth factor-β (TGF-β) and IL-10 were reduced in the contralateral spinal dorsal horn (L4–L6), an intrathecal supplement of exogenous TGF-β, or IL-10 attenuated IL-6-evoked tactile allodynia. Further studies demonstrated that intrarubral pretreatment with JAK2/STAT3 inhibitor AG490 suppressed the elevations of spinal TNF-α, IL-1β, and IL-6 and promoted the expressions of TGF-β and IL-10 in IL-6-evoked tactile allodynia rats. However, intrarubral pretreatment with ERK inhibitor PD98059 only restrained the increase in spinal TNF-α and enhanced the expression of spinal IL-10. These findings imply that rubral IL-6 plays descending facilitation and produces algesic effect through upregulating the expressions of spinal pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 and downregulating the expressions of spinal anti-inflammatory cytokines TGF-β and IL-10 by activating JAK2/STAT3 and/or ERK pathways, which provides potential therapeutic targets for the treatment of pathological pain.

28 February 2024 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
CWChuhui Wang
Chuhui Wang
CBChuqi Bai
Chuqi Bai
KCKeyu Chen
Keyu Chen
QDQian Du
Qian Du
SCShiqi Cheng
Shiqi Cheng
YDYalin Dong
Yalin Dong